These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 22797382)
1. Research in pancreatic cancer: an update after ASCO 2012. Saif MW JOP; 2012 Jul; 13(4):330-1. PubMed ID: 22797382 [No Abstract] [Full Text] [Related]
2. [Postoperative adjuvant treatment for pancreatic cancer: present status and future perspective]. Uesaka K; Kanemoto H; Sugiura T; Mizuno T; Okamura Y; Kinugasa Y; Bando E; Terashima M Gan To Kagaku Ryoho; 2011 Sep; 38(9):1403-5. PubMed ID: 21918335 [TBL] [Abstract][Full Text] [Related]
3. [Chemotherapy in adenocarcinomas of the pancreas]. Huguier M Gastroenterol Clin Biol; 2002 Nov; 26(11):1063; discussion 1063-4. PubMed ID: 12483149 [No Abstract] [Full Text] [Related]
4. Prolonging survival in inoperable pancreatic cancer with combination chemotherapy. Goel AK; Seenu V Trop Gastroenterol; 1995; 16(2):141-3. PubMed ID: 8644365 [No Abstract] [Full Text] [Related]
5. [Chemotherapy of cancer of the exocrine pancreas]. Bonneterre J Bull Cancer; 1990; 77(3):267-74. PubMed ID: 2140281 [TBL] [Abstract][Full Text] [Related]
6. Chemoradiotherapy for pancreatic cancer: current status and perspectives. Oya N Int J Clin Oncol; 2004 Dec; 9(6):451-7. PubMed ID: 15616875 [TBL] [Abstract][Full Text] [Related]
7. [Is there an advantage to neo- or adjuvant chemotherapy in pancreatic cancer?]. Klapdor R Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():135-47. PubMed ID: 1724194 [TBL] [Abstract][Full Text] [Related]
8. The first-line treatment for advanced pancreatic cancer. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010. Merl MY; Li J; Saif MW JOP; 2010 Mar; 11(2):148-50. PubMed ID: 20208324 [TBL] [Abstract][Full Text] [Related]
10. A review of systemic therapy for advanced pancreatic cancer. El-Rayes BF; Philip PA Clin Adv Hematol Oncol; 2003 Jul; 1(7):430-4. PubMed ID: 16258429 [TBL] [Abstract][Full Text] [Related]
11. The case for routine use of adjuvant therapy in pancreatic cancer. Kennedy EP; Yeo CJ J Surg Oncol; 2007 Jun; 95(7):597-603. PubMed ID: 17230543 [TBL] [Abstract][Full Text] [Related]
12. [Update on gastroenterology]. Ychou M; Senesse P; Quenet F Bull Cancer; 1998 Jan; 85(1):37-41. PubMed ID: 9752344 [No Abstract] [Full Text] [Related]
13. [Problems of antineoplastic chemotherapy of pancreatic cancer]. Matthias M; Wolff H Zentralbl Chir; 1987; 112(21):1322-36. PubMed ID: 3324556 [TBL] [Abstract][Full Text] [Related]
14. Novel agents for the treatment of pancreatic adenocarcinoma. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011. Cheng H; Merika E; Syrigos KN; Saif MW JOP; 2011 Jul; 12(4):334-8. PubMed ID: 21737890 [TBL] [Abstract][Full Text] [Related]
15. Conclusions from the European Study Group for Pancreatic Cancer adjuvant trial of chemoradiotherapy and chemotherapy for pancreatic cancer. Ghaneh P; Neoptolemos JP Surg Oncol Clin N Am; 2004 Oct; 13(4):567-87, vii-viii. PubMed ID: 15350935 [TBL] [Abstract][Full Text] [Related]
16. Current status of chemotherapy in metastatic pancreatic cancer. Wils JA Anticancer Res; 1989; 9(4):1027-31. PubMed ID: 2683988 [TBL] [Abstract][Full Text] [Related]